Detecting Neurobehavioral Effects
Does a potential new blood pressure drug have negative effects on the nervous system? Which therapies show the most promise for treatment of Alzheimer’s disease? Are growing rates of neuropsychiatric disorders, such as Attention Deficit Hyperactivity
Disorder (ADHD) and autism, linked to chemical exposure? How can we protect soldiers and civilians who are at risk from exposure to chemical weapons?
Neurobehavioral testing aims to answer these and other important questions. But all testing preclinical CROs are not created equal. This white paper will help you choose the right partner for your specific neuro-tox challenge.